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Historical profile and perspectives in Oncology
Maria Aparecida Azevedo Koike Folgueira
Although our medical school has been created more than a century ago, clinical oncology, 
as an organized and comprehensive discipline, has a 
relatively recent history. For a long time, education in 
clinical oncology was spread through various clinical and 
surgical disciplines in the undergraduate curriculum from 
Faculdade de Medicina da Universidade de São Paulo - 
FMUSP. In accordance, at Hospital das Clínicas (HC) da 
FMUSP, patient care in clinical oncology was given by 
medical doctors from a large gamma of specialties, as well 
as by radiotherapists and hematologists. In our school, the 
dawn of Oncology may be associated with professionals 
involved in these areas as well as with biochemistry and 
pathology.
During the years, there was a lot of debate about 
the introduction of Oncology as a discipline in FMUSP, 
as well as an Oncology Unit, to treat patients. In 1963, the 
creation of the Oncology Center (Centro de Oncologia, 
CEON) was approved, then, in 1968, an Administrative 
Council was set, and afterwards, in 1971, a location, the 
old Biothery building, was decided. At the same period, 
in 1970, following the academic reform, the Biochemistry 
discipline, including Prof. Ricardo Brentani and Prof. 
Mitzi Brentani, was transferred to the University main 
campus, along with other basic disciplines of the medical 
curriculum. In 1973, the creation of the Department of 
Oncology was proposed by Prof Charles Corbett, including 
two disciplines: Community Oncology and Cellular and 
Experimental Oncology. Afterwards, in 1974-1975, a 
huge initiative gave rise to the implementation of the 
“Laboratories of Medical Investigation” (Laboratórios 
de Investigação Médica, LIM), including the Lab of 
Experimental Oncology, chaired by Prof Ricardo Brentani 
and co-chaired by Prof Mitzi, and a few years later, in 
1980, Prof Brentani assumed the recently created Chair of 
Oncology, as a full professor (Prof titular de Terapêutica 
Clínica II-Oncologia) from the Department of Clinical 
Medicine. As a result, faculty members from the Oncology 
discipline were invited to teach topics in Oncology in the 
Pathology undergraduate course. This was the embrio 
of an undergraduate course, totally dedicated to Clinical 
Oncology, introduced in the medical curriculum some 
years later, in 1994. In addition, a graduate “stricto sensu” 
program, with master and PhD degrees, was established 
in 1989. During this period, oncology care at Hospital 
das Clínicas was not centralized and cancer patients were 
treated in many different clinical services, according to 
tumor primary site, except for radiotherapy and systemic 
therapy, which were administered at Instituto de Radiologia 
and chemotherapy room, at Prédio dos Ambulatórios (6th 
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floor), respectively. Consequently, in 1994, hospital services 
of Clinical Oncology and Radiotherapy were united in the 
newly created Radiology Institute (Instituto de Radiologia 
– INRAD) and Radiology Department. Afterwards, medical 
residency in Clinical Oncology was established in 1998, 
with two places per year and at last, in 2006, the Oncology 
Center, beside INRAD, was inaugurated by Gov. Cláudio 
Lembo. By this time, FMUSP had a complete education 
program in Oncology.
Prof Brentani, retired in 2007, was the first full 
professor in Oncology in Brazil and the Oncology discipline 
at FMUSP was the first comprehensive undergraduate 
course and graduate program introduced in our country. In 
this mission, Prof Brentani counted on the collaboration of 
Prof Mitzi, Prof Miriam Hatue Honda Federico, Prof Roger 
Chammas, Prof Maria Aparecida Azevedo Koike Folgueira, 
Dr. Maria del Pilar Estevez Diz, Dr. Igor Snitcovsky, Prof. 
Maria Aparecida Nagai and Prof Shigueko Sonohara 
Troyano Pueyo.
But then a new chapter began with new protagonists. 
The number of cancer patients kept on growing demanding 
a state government intervention to improve patient care. In 
a huge effort of Governor José Serra and Faculty members 
of FMUSP, including Prof Giovanni Guido Cerri, Prof 
Paulo Marcelo Gehm Hoff and Prof. Roger Chammas, 
the skeleton of the building planned to house the Women 
Institute gave rise to the 28 floors of the Cancer Institute 
(Instituto do Câncer do Estado de São Paulo, ICESP), 
inaugurated in 2008, and nowadays the largest hospital 
in Latin America, totally dedicated to cancer care. ICESP 
allowed the integration of health professionals from the 
system Hospital das Clínicas – FMUSP, involved in 
cancer treatment, in an innovative concept of care delivery, 
benefitting patients, who may have all stages of their care, 
from diagnosis to rehabilitation, in the same location. 
Recognizing the advantage of such approach, only a few 
years after its inauguration, ICESP was ranked 1st place in 
a satisfaction opinion research, performed among patients 
from hospitals from the Brazilian Unified Health System 
(Sistema Único de Saúde, SUS), sponsored by São Paulo 
State Health Secretary (Secretaria de Estado da Saúde, 
SES) in 2011. ICESP, with 499 hospital beds, 85 intensive 
care unit (ICU) beds, 107 chemotherapy chairs, was the 
stage in 2013 of 202,064 medical appointments, 8,277 
surgeries, 54,707 chemotherapy sessions and 59,401 
radiotherapy sessions. In connection with these facts, 
there was a renewed interest in Oncology residency, and 
the number of new places grew to 14 per year. Nowadays, 
ICESP is one of the main training centers In Oncology in 
Brazil and our ex-residents are spread all over the national 
territory.
Following the university main focus in education, 
research and community care, in 2011, the Translational 
Center for Oncology Investigation (Centro de Investigação 
Translacional em Oncologia, CiTO), was inaugurated 
on the 8th floor of ICESP, with research laboratories and 
multi-user equipment facilities, regarding all the main up 
to date techniques used in biomarkers research, molecular 
oncology, therapeutic innovation, including pre-clinical 
to clinical research areas. Moreover, the creation of the 
Biobank will allow a boost in translational research in the 
next few years.
In oncology, we may say that professors and 
researchers from FMUSP-ICESP-CTO are leaders in 
clinical and translational research. This activity translates 
in the attraction of clinical trials and cooperative studies 
for the center, with a direct impact in patient care, who 
may have access to innovative treatments. Concerning 
public policies we can mention the pioneering work 
“Manual of procedures in Oncology - Manual de Condutas 
em Oncologia” edited by members of USP Oncology 
Discipline and medical doctors from ICESP, aimed at 
guidance on clinical treatment of cancer patients. This 
manual, based on medical literature, firstly published in 
2003 and rewritten periodically thereafter, was endorsed 
by the Secretary of Health from São Paulo State, in order 
to direct the access of any patient to molecular therapy.
What about the future? Patients are having a good 
standard of care and having the opportunity to engage in 
clinical trials, in cancer prevention and early detection 
programs, and a research network is already in place. 
Although a remarkable progress has been achieved, cancer 
is still an important cause of mortality and morbidity. 
Nevertheless, more cancer patients are expected in the years 
to come, as life expectancy increases and other chronic 
diseases are better controlled.
But the horizon seems to get clearer in the Oncology 
area. Cancer heterogeneity is a challenge that may be 
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partly solved through next generation sequencing of 
tumor genomes. New targets will fuel the cancer tailored 
treatments. Fresh tumor engraftment and expansion in 
animals will allow targeted therapies to be tested for each 
individual tumor. In addition, the development of more 
precise robotic surgical devices will allow less traumatic 
surgeries and nanotechnology will enable the development 
of new ways to deliver drugs more effectively to cancer 
cells.
In the last 100 years, from the mustard gas, used 
on the trenches of the I World War, the first chemotherapy 
agent was developed. For the next 100 years we can preview 
a new era on cancer treatment based on tumor targets and 
personalized treatment.
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